1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Intron Biotechnology Co., Ltd.

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

1999

Location

Seongnam Gyeonggi-do South Korea

Primary Industry

Biotechnology

About

Established in 1999 and based in Seongnam-si, South Korea, Intron Biotechnology Co., Ltd. operates as a biotechnology company that focuses on R&D in antibacterial drugs targeting MRSA as well as other antibiotic resistant bacteria.
Current Investors
IMM Private Equity

Request a demo to show more

Primary Industry
Biotechnology
Sub Industries
Biopharmaceuticals, Pharmaceutical Research & Development
Website
www.intron.co.kr
Verticals
HealthTech, Manufacturing
Company Stage
Mature - Growth Capital
Total Amount Raised
Subscriber access only

Deals

Deals Type
PIPE
Deal Status Target (s) Deal Date Investor(s) Seller(s) Deal size (Mn) Enterprise value (Mn) Post-money valuation (Mn) EBITDA multiple (x) Revenue multiple (x) Lead partner (s)
Completed Intron Biotechnology Co., Ltd. 02 Feb 2016
Displaying 1-1 of 1

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.